Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329848 · ClinicalTrials.gov registry record
Accommodation Disorders
A clinical trial, sponsored by Western University of Health Sciences.
- Completed
- Registry status
- 83
- Enrollment target
NCT01329848: Completed study, sponsored by Western University of Health Sciences.
NCT01329848 is a clinical trial that has completed, run by Western University of Health Sciences. The registered enrollment target is 83 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01329848 has completed, sponsored by Western University of Health Sciences.
- COMPLETED
- Registry status
- 83 participants
- Enrollment target
Study Summary
This project will develop clinically useful, objective measurements of accommodative insufficiency and fatigue using continuous autorefraction recordings. The development of these procedures will help vision care professionals diagnose and treat accommodative anomalies.
Primary Outcome
Lag will be measured at different viewing distances and durations using autorefraction. Accommodation error refers to the difference between the distance where the target is located and where the eyes focus. Lag refers error that is under focussed; lead is error that is over focussed. This distance is measured in diopters, or 1/meter.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2010-12 |
| Est. Completion | 2013-08 |
What the finished NCT01329848 record still lists
NCT01329848 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01329848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01329848 about?
NCT01329848 is a clinical study titled "Accommodation Disorders". This project will develop clinically useful, objective measurements of accommodative insufficiency and fatigue using continuous autorefraction recordings. The development of these procedures will help vision care professionals diagnose and treat accommodative anomalies.
What is the current status of trial NCT01329848?
This trial is currently completed. The enrollment target is 83 participants. The study started on 2010-12. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT01329848?
This trial is sponsored by Western University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02974647 · 83 participants · Phase 2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- NCT03919292 · 83 participants · Phase 1
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- NCT04626674 · 83 participants · Phase 1
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)
- NCT05277168 · 83 participants · Phase 1
A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia